ATLN
Atlantic International Corp.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$0.90
+0.00%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.39x
- Price / sales
- 0.12x
- Price / cash flow
- -2.48x
Enterprise value
- Enterprise value
- $368.7M
- EV / sales
- 0.63x
- EV / EBITDA
- -6.35x
- EV / EBIT
- -6.62x
- Market cap
- $71.4M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Mar 1, 2026